Browsing by Author Sharma, Vijay K

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2017Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc AnalysisAnderson, Craig; Lindley, Richard; Carr, Sue; Chalmers, John; Kim, J S; Lavados, Pablo; Lee, Tsong-Hai; Olavarria, Veronica V; Pontes-Neto, Octavio; Ricci, S; Robinson, Thompson G.; Rodriguez, Jorge; Sato, Shoichiro; Sharma, Vijay K; Wang, X; Woodward, Mark; School of Public Health: Public Health; Westmead Clinical School: MedicineInfluence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis, Stroke, vol.48, 9, 2017,pp 2605-2609
2016Low-dose versus standard-dose intravenous alteplase in acute ischemic strokeAnderson, Craig; Arima, Hisatomi; Billot, Laurent; Chalmers, John; Chen, Xiaoying; Li, Qiang; Lindley, Richard; Wang, Xiaosuo; Woodward, Mark; Broderick, Joseph; Cao, Y; Chen, G; et al, Various; Kim, J S; Lavados, Pablo; Lee, T H; Parsons, M.W.; Robinson, Thompson G.; Sharma, Vijay K; Thang, N.H.; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; Western Clinical School: Medicine (Westmead); School of Medical Sciences: Bosch Institute; The George Institute for Global HealthLow-dose versus standard-dose intravenous alteplase in acute ischemic stroke, The New England Journal of Medicine, vol.374, 24, 2016,pp 2313-2323
2015Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2×2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatmentAnderson, Craig; Arima, Hisatomi; Chalmers, John; Chen, Xiaoying; Fuentes, Sully; Lindley, Richard; Woodward, Mark; et al, Various; Huang, Yining; Kim, Jong S.; Lavados, Pablo; Lee, Tsong-Hai; Levi, Christopher; Nguyen, Huy Thang; Olavarria, Veronica; Parsons, Mark; Robinson, Thompson; Sharma, Vijay K; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; Western Clinical School: Medicine (Westmead); The George Institute for Global HealthRationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2×2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment, International Journal of Stroke, vol.10, 5, 2015,pp 778-788